What is the current glycopyrrolate injection market size?

The glycopyrrolate injection market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the glycopyrrolate injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the glycopyrrolate injection market?

Key drivers include rising healthcare expenditures and growing prevalence of respiratory disorders.

What challenges does the glycopyrrolate injection market face?

Challenges include stringent regulatory requirements and intense competition among manufacturers.

Which regions are the leaders in the glycopyrrolate injection market?

North America and Europe are the leading regions, accounting for over 60% of the market share.

Who are the top companies in the glycopyrrolate injection market?

Top companies include Pfizer, Merck, and Novartis, which hold significant market share.

What future opportunities exist in the glycopyrrolate injection market?

Future opportunities include emerging markets and increasing adoption of generic versions.

How does technology impact the glycopyrrolate injection market?

Advances in technology improve manufacturing processes and enhance product quality.

What is the regulatory landscape for the glycopyrrolate injection market?

The market is subject to strict regulations, including FDA approvals and compliance with GMP standards.

What is the future outlook for the glycopyrrolate injection market?

The future outlook is positive, with growing demand and increasing adoption of glycopyrrolate injections.

What Is the Global glycopyrrolate injection Market Worth in 2026?

glycopyrrolate injection by Application (Hospitals, Clinics, Others), by Types (0.2mg/ml, 0.4mg/2ml, 1mg/5ml, 4mg/20ml), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

glycopyrrolate injection Market Overview

The glycopyrrolate injection market refers to the global market for glycopyrrolate injections, which are used to treat various medical conditions, including reducing salivation, bronchial secretions, and other conditions. As an executive-ready overview, the glycopyrrolate injection market size is estimated to be around $143 million in 2025, with a growth outlook that is expected to drive the market forecast towards significant industry expansion. The scope of this market includes the glycopyrrolate injection market size, growth rate, and market forecast, with a focus on regional analysis and competitive landscape. The market is expected to grow at a CAGR of 4.5% from 2026 to 2033, driven by macro drivers such as increasing demand for anticholinergic medications and advancements in healthcare infrastructure.

Loading chart…

Key forces shaping the glycopyrrolate injection market include technology shifts towards more efficient manufacturing processes, regulations related to pharmaceutical safety and efficacy, and consumer behavior driven by increasing awareness of healthcare options. The largest region in the glycopyrrolate injection market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and improving infrastructure. Overall, the glycopyrrolate injection market is expected to experience significant growth over the forecast period, driven by a combination of factors including increasing demand, advancements in technology, and expanding distribution channels.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	654.79 million
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Accord Healthcare; Advanz Pharma; American Regent; Amneal Pharmaceuticals; Apotex; BE Pharmaceuticals; BluePoint Laboratories; Caplin Steriles; Civica; Fresenius Kabi; Gland Pharma; Hikma; Khandelwal Laboratories; Meitheal; Nivagen Pharmaceuticals; NorthStar Rx; Sandoz; Solco Healthcare; SteriMax; Xiromed; AuroMedics Pharma; Par Pharmaceutical; Piramal Critical Care; Somerset Therapeutics; West-ward Pharmaceutical; Zydus Pharmaceuticals; Hengrui Pharmaceuticals; Jiabo Pharmaceutical; Easton Biopharmaceuticals; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The glycopyrrolate injection market is poised for significant growth, driven by various factors that are shaping its trajectory. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that are critical to understanding the glycopyrrolate injection market size and growth forecast.

Growth Drivers2 items

Increasing demand for glycopyrrolate injection in the treatment of various medical conditions, such as reducing salivation and respiratory secretions during surgery, is driving the market growth

Advancements in medical technology and the development of new formulations are expanding the applications of glycopyrrolate injection, further fueling the market growth

Restraints2 items

Stringent regulatory requirements and the need for compliance with good manufacturing practices are limiting the entry of new players in the glycopyrrolate injection market

The availability of alternative treatments and the high cost of glycopyrrolate injection are restraining the market growth, particularly in price-sensitive regions

Opportunities2 items

The growing demand for glycopyrrolate injection in emerging economies is creating opportunities for market players to expand their presence and increase their market share

The development of novel formulations and the increasing focus on personalized medicine are expected to drive the growth of the glycopyrrolate injection market in the coming years

Challenges2 items

The glycopyrrolate injection market is highly competitive, with several established players competing for market share, making it challenging for new entrants to establish themselves

The market is also facing challenges related to supply chain disruptions and pricing pressures, which are affecting the profitability of market players and the overall growth forecast of the market

Market Segmentation

Loading chart…

The Application segment of the glycopyrrolate injection market refers to the various uses of glycopyrrolate injections in medical settings. This segmentation category contributes significantly to the overall glycopyrrolate injection market size, as different applications drive demand for the product. Understanding the glycopyrrolate injection segmentation by application is crucial for market players to identify areas of growth and opportunity. The applications of glycopyrrolate injections include reducing salivation, bronchial secretions, and other bodily secretions during surgical procedures, as well as managing conditions such as peptic ulcer disease and gastroesophageal reflux disease.

The Types segment of the glycopyrrolate injection market encompasses various subtypes, including [object Object] and [object Object]. This segmentation category provides insights into the different formulations and concentrations of glycopyrrolate injections available in the market. The types of glycopyrrolate injections vary in terms of their dosage strength, formulation, and packaging, which affects their adoption and usage patterns. Analyzing the market taxonomy of glycopyrrolate injections by type helps stakeholders understand the competitive landscape and identify gaps in the market. Furthermore, the glycopyrrolate injection segmentation by type enables companies to develop targeted marketing strategies and product development plans.

glycopyrrolate injection Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

0.2mg/ml

0.4mg/2ml

1mg/5ml

4mg/20ml

Regional Insights

Loading chart…

The glycopyrrolate injection market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and Latin America being the fastest-growing region, driven by increasing adoption of glycopyrrolate injections in the healthcare sector. Key drivers for North America include investments in infrastructure, a mature ecosystem, and favorable policies. In Europe, key drivers include a high level of ecosystem maturity, significant investments in research and development, and a large patient population.

In Asia Pacific, key drivers include a large and growing patient population, increasing adoption of glycopyrrolate injections, and significant investments in healthcare infrastructure. Latin America is driven by increasing demand for glycopyrrolate injections, improving infrastructure, and government initiatives to enhance healthcare services. The Middle East & Africa region is driven by a growing patient population, increasing awareness about glycopyrrolate injections, and government initiatives to improve healthcare services. The regional forecast indicates a significant growth opportunity in the glycopyrrolate injection market, driven by these key drivers.

Competitive Landscape

The glycopyrrolate injection market exhibits a moderately consolidated structure, with a mix of global players and local/regional companies competing for market share. The glycopyrrolate injection competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves and gain a competitive edge. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To mitigate these risks, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate their products and services.

Accord Healthcare: regional expansion

Fresenius Kabi: innovation pipeline

Hikma: premium pricing

Sandoz: OEM tie-ups

Piramal Critical Care: local manufacturing

AuroMedics Pharma: vertical integration

Key glycopyrrolate injection Companies30 items

Accord Healthcare

Advanz Pharma

American Regent

Amneal Pharmaceuticals

Apotex

BE Pharmaceuticals

BluePoint Laboratories

Caplin Steriles

Civica

Fresenius Kabi

Gland Pharma

Hikma

Khandelwal Laboratories

Meitheal

Nivagen Pharmaceuticals

NorthStar Rx

Sandoz

Solco Healthcare

SteriMax

Xiromed

AuroMedics Pharma

Par Pharmaceutical

Piramal Critical Care

Somerset Therapeutics

West-ward Pharmaceutical

Zydus Pharmaceuticals

Hengrui Pharmaceuticals

Jiabo Pharmaceutical

Easton Biopharmaceuticals

Segments

Market Ecosystem

The glycopyrrolate injection ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly categorized into three main segments: upstream, midstream, and downstream. Upstream participants include technology providers and suppliers, while midstream comprises integrators and channels, and downstream consists of end users. The value in this ecosystem is created and captured through the interactions and relationships among these participants, ultimately resulting in the delivery of glycopyrrolate injection products to end users.

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce glycopyrrolate injection products

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish and enforce quality standards

End users / buyers — receive and administer glycopyrrolate injections

Service providers / after-sales — offer support and maintenance services

Data/analytics providers — provide insights on market trends and product usage

In the glycopyrrolate injection ecosystem, control points are primarily influenced by regulators and standards bodies, as they dictate the quality and safety standards for these products. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and standards approvals, which can impact the production and distribution of glycopyrrolate injections. Furthermore, switching costs and partnerships between participants can affect the overall efficiency of the ecosystem. A thorough value chain analysis of the glycopyrrolate injection ecosystem can help identify these complexities and provide insights into the intricate relationships among participants.

Recent Industry Insights

The glycopyrrolate injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have led to the expansion of product portfolios and enhanced distribution networks. Notably, several mergers and acquisitions have taken place, resulting in increased market consolidation and competitiveness. Additionally, there have been product launches and technological advancements that have improved the efficacy and safety of glycopyrrolate injections, catering to the evolving needs of healthcare providers and patients.

Furthermore, regulatory changes have influenced the glycopyrrolate injection market, with a greater emphasis on ensuring compliance with stringent quality standards. The industry has also experienced a shift in consumer trends, with a growing demand for convenient and cost-effective treatment options. To address this, companies have been focusing on funding rounds and expansions to enhance their manufacturing capabilities and develop more patient-centric solutions, ultimately driving growth in the glycopyrrolate injection industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the glycopyrrolate injection market. The market attractiveness is moderate, driven by the increasing demand for anticholinergic medications. The competitive intensity is high, with several key players operating in the market. The long-term outlook for the glycopyrrolate injection market is positive, with a growing demand for effective treatments. The innovation landscape is evolving, with a focus on developing new formulations and delivery systems. The demand-supply balance is expected to be stable, with manufacturers increasing production to meet the growing demand. Key risk factors include regulatory changes and intense competition. The glycopyrrolate injection market outlook is expected to be driven by the increasing prevalence of medical conditions requiring anticholinergic treatments.

12 items

1. Executive Summary

2. glycopyrrolate injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global glycopyrrolate injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global glycopyrrolate injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global glycopyrrolate injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global glycopyrrolate injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global glycopyrrolate injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global glycopyrrolate injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global glycopyrrolate injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global glycopyrrolate injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global glycopyrrolate injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global glycopyrrolate injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global glycopyrrolate injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global glycopyrrolate injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global glycopyrrolate injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global glycopyrrolate injection Market Competition by Key Manufacturers

9.1. Global glycopyrrolate injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global glycopyrrolate injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Accord Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Advanz Pharma

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. American Regent

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Amneal Pharmaceuticals

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Apotex

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. BE Pharmaceuticals

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. BluePoint Laboratories

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Caplin Steriles

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Civica

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Fresenius Kabi

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Gland Pharma

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hikma

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Khandelwal Laboratories

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Meitheal

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Nivagen Pharmaceuticals

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. NorthStar Rx

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Sandoz

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Solco Healthcare

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. SteriMax

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Xiromed

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. AuroMedics Pharma

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Par Pharmaceutical

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Piramal Critical Care

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Somerset Therapeutics

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. West-ward Pharmaceutical

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

10.26. Zydus Pharmaceuticals

10.26.1. Company Basic Information and Sales Area

10.26.2. Main Business/Business Overview

10.26.3. Product Portfolio

10.26.4. Financial

10.26.5. Recent Industry Insights

10.26.6. SWOT Analysis

10.27. Hengrui Pharmaceuticals

10.27.1. Company Basic Information and Sales Area

10.27.2. Main Business/Business Overview

10.27.3. Product Portfolio

10.27.4. Financial

10.27.5. Recent Industry Insights

10.27.6. SWOT Analysis

10.28. Jiabo Pharmaceutical

10.28.1. Company Basic Information and Sales Area

10.28.2. Main Business/Business Overview

10.28.3. Product Portfolio

10.28.4. Financial

10.28.5. Recent Industry Insights

10.28.6. SWOT Analysis

10.29. Easton Biopharmaceuticals

10.29.1. Company Basic Information and Sales Area

10.29.2. Main Business/Business Overview

10.29.3. Product Portfolio

10.29.4. Financial

10.29.5. Recent Industry Insights

10.29.6. SWOT Analysis

10.30. Segments

10.30.1. Company Basic Information and Sales Area

10.30.2. Main Business/Business Overview

10.30.3. Product Portfolio

10.30.4. Financial

10.30.5. Recent Industry Insights

10.30.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global glycopyrrolate injection Market

Figure 4: Global glycopyrrolate injection Market: Drivers

Figure 5: Global glycopyrrolate injection Market: Challenges

Figure 6: Global glycopyrrolate injection Market: Trends

Figure 7: Global glycopyrrolate injection Market: Opportunity

Figure 8: Global glycopyrrolate injection Market: Restraint

Figure 9: Global glycopyrrolate injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global glycopyrrolate injection Market Value (USD Million) By Region

Figure 19: Global glycopyrrolate injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global glycopyrrolate injection Market Value (USD Million) By Region

Figure 27: Global glycopyrrolate injection Market Share (%) By: Regions (2032)

Figure 28: Global glycopyrrolate injection Market Volume (K) By Region

Figure 29: Global glycopyrrolate injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global glycopyrrolate injection Market Value (USD Million) By Region

Figure 37: Global glycopyrrolate injection Market Share (%) By: Regions (2032)

Figure 38: Global glycopyrrolate injection Market Volume (K) By Region

Figure 39: Global glycopyrrolate injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

155 items

Table 1: Market Segmentation Analysis

Table 2: Global glycopyrrolate injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global glycopyrrolate injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global glycopyrrolate injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global glycopyrrolate injection Market Value (USD Million) By Region

Table 14: Global glycopyrrolate injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global glycopyrrolate injection Market Volume (K) By Region

Table 31: Global glycopyrrolate injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global glycopyrrolate injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global glycopyrrolate injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global glycopyrrolate injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Accord Healthcare Basic Information And Sales Area

Table 52: Accord Healthcare. Products Portfolio

Table 53: Advanz Pharma Basic Information And Sales Area

Table 54: Advanz Pharma. Products Portfolio

Table 55: American Regent Basic Information And Sales Area

Table 56: American Regent. Products Portfolio

Table 57: Amneal Pharmaceuticals Basic Information And Sales Area

Table 58: Amneal Pharmaceuticals. Products Portfolio

Table 59: Apotex Basic Information And Sales Area

Table 60: Apotex. Products Portfolio

Table 61: BE Pharmaceuticals Basic Information And Sales Area

Table 62: BE Pharmaceuticals. Products Portfolio

Table 63: BluePoint Laboratories Basic Information And Sales Area

Table 64: BluePoint Laboratories. Products Portfolio

Table 65: Caplin Steriles Basic Information And Sales Area

Table 66: Caplin Steriles. Products Portfolio

Table 67: Civica Basic Information And Sales Area

Table 68: Civica. Products Portfolio

Table 69: Fresenius Kabi Basic Information And Sales Area

Table 70: Fresenius Kabi. Products Portfolio

Table 71: Gland Pharma Basic Information And Sales Area

Table 72: Gland Pharma. Products Portfolio

Table 73: Hikma Basic Information And Sales Area

Table 74: Hikma. Products Portfolio

Table 75: Khandelwal Laboratories Basic Information And Sales Area

Table 76: Khandelwal Laboratories. Products Portfolio

Table 77: Meitheal Basic Information And Sales Area

Table 78: Meitheal. Products Portfolio

Table 79: Nivagen Pharmaceuticals Basic Information And Sales Area

Table 80: Nivagen Pharmaceuticals. Products Portfolio

Table 81: NorthStar Rx Basic Information And Sales Area

Table 82: NorthStar Rx. Products Portfolio

Table 83: Sandoz Basic Information And Sales Area

Table 84: Sandoz. Products Portfolio

Table 85: Solco Healthcare Basic Information And Sales Area

Table 86: Solco Healthcare. Products Portfolio

Table 87: SteriMax Basic Information And Sales Area

Table 88: SteriMax. Products Portfolio

Table 89: Xiromed Basic Information And Sales Area

Table 90: Xiromed. Products Portfolio

Table 91: AuroMedics Pharma Basic Information And Sales Area

Table 92: AuroMedics Pharma. Products Portfolio

Table 93: Par Pharmaceutical Basic Information And Sales Area

Table 94: Par Pharmaceutical. Products Portfolio

Table 95: Piramal Critical Care Basic Information And Sales Area

Table 96: Piramal Critical Care. Products Portfolio

Table 97: Somerset Therapeutics Basic Information And Sales Area

Table 98: Somerset Therapeutics. Products Portfolio

Table 99: West-ward Pharmaceutical Basic Information And Sales Area

Table 100: West-ward Pharmaceutical. Products Portfolio

Table 101: Zydus Pharmaceuticals Basic Information And Sales Area

Table 102: Zydus Pharmaceuticals. Products Portfolio

Table 103: Hengrui Pharmaceuticals Basic Information And Sales Area

Table 104: Hengrui Pharmaceuticals. Products Portfolio

Table 105: Jiabo Pharmaceutical Basic Information And Sales Area

Table 106: Jiabo Pharmaceutical. Products Portfolio

Table 107: Easton Biopharmaceuticals Basic Information And Sales Area

Table 108: Easton Biopharmaceuticals. Products Portfolio

Table 109: Segments Basic Information And Sales Area

Table 110: Segments. Products Portfolio

Table 111: Global Market Value (USD Million) (2025-2032) By Application

Table 112: Global Market Share (%) By Application (2032)

Table 113: Global Market Value (USD Million) (2025-2032) By Types

Table 114: Global Market Share (%) By Types (2032)

Table 115: Global Market Volume (K) (2025-2032) By Application

Table 116: Global Market Share (%) By Application (2032)

Table 117: Global Market Volume (K) (2025-2032) By Types

Table 118: Global Market Share (%) By Types (2032)

Table 119: Global glycopyrrolate injection Market Value (USD Million) By Region

Table 120: Global glycopyrrolate injection Market Share (%) By Region (2025-2032)

Table 121: North America Market Value (USD Million) (2025-2032) By Country

Table 122: North America Market Value (USD Million) (2025-2032) By Application

Table 123: North America Market Value (USD Million) (2025-2032) By Types

Table 124: Europe Market Value (USD Million) (2025-2032) By Country

Table 125: Europe Market Value (USD Million) (2025-2032) By Application

Table 126: Europe Market Value (USD Million) (2025-2032) By Types

Table 127: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 128: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 129: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 130: South America Market Value (USD Million) (2025-2032) By Country

Table 131: South America Market Value (USD Million) (2025-2032) By Application

Table 132: South America Market Value (USD Million) (2025-2032) By Types

Table 133: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 134: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 135: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 136: Global glycopyrrolate injection Market Volume (K) By Region

Table 137: Global glycopyrrolate injection Market Share (%) By Region (2025-2032)

Table 138: North America Market Volume (K) (2025-2032) By Country

Table 139: North America Market Volume (K) (2025-2032) By Application

Table 140: North America Market Volume (K) (2025-2032) By Types

Table 141: Europe Market Volume (K) (2025-2032) By Country

Table 142: Europe Market Volume (K) (2025-2032) By Application

Table 143: Europe Market Volume (K) (2025-2032) By Types

Table 144: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 145: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 146: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 147: South America Market Volume (K) (2025-2032) By Country

Table 148: South America Market Volume (K) (2025-2032) By Application

Table 149: South America Market Volume (K) (2025-2032) By Types

Table 150: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 151: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 152: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 153: Research Programs/Design For This Report

Table 154: Key Data Information From Secondary Sources

Table 155: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

glycopyrrolate injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	654.79 million
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Accord Healthcare; Advanz Pharma; American Regent; Amneal Pharmaceuticals; Apotex; BE Pharmaceuticals; BluePoint Laboratories; Caplin Steriles; Civica; Fresenius Kabi; Gland Pharma; Hikma; Khandelwal Laboratories; Meitheal; Nivagen Pharmaceuticals; NorthStar Rx; Sandoz; Solco Healthcare; SteriMax; Xiromed; AuroMedics Pharma; Par Pharmaceutical; Piramal Critical Care; Somerset Therapeutics; West-ward Pharmaceutical; Zydus Pharmaceuticals; Hengrui Pharmaceuticals; Jiabo Pharmaceutical; Easton Biopharmaceuticals; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for glycopyrrolate injection in the treatment of various medical conditions, such as reducing salivation and respiratory secretions during surgery, is driving the market growth

Advancements in medical technology and the development of new formulations are expanding the applications of glycopyrrolate injection, further fueling the market growth

Restraints2 items

Stringent regulatory requirements and the need for compliance with good manufacturing practices are limiting the entry of new players in the glycopyrrolate injection market

The availability of alternative treatments and the high cost of glycopyrrolate injection are restraining the market growth, particularly in price-sensitive regions

Opportunities2 items

The growing demand for glycopyrrolate injection in emerging economies is creating opportunities for market players to expand their presence and increase their market share

The development of novel formulations and the increasing focus on personalized medicine are expected to drive the growth of the glycopyrrolate injection market in the coming years

Challenges2 items

The glycopyrrolate injection market is highly competitive, with several established players competing for market share, making it challenging for new entrants to establish themselves

Market Segmentation

Loading chart…

glycopyrrolate injection Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

0.2mg/ml

0.4mg/2ml

1mg/5ml

4mg/20ml

Regional Insights

Loading chart…

Competitive Landscape

Accord Healthcare: regional expansion

Fresenius Kabi: innovation pipeline

Hikma: premium pricing

Sandoz: OEM tie-ups

Piramal Critical Care: local manufacturing

AuroMedics Pharma: vertical integration

Key glycopyrrolate injection Companies30 items

Accord Healthcare

Advanz Pharma

American Regent

Amneal Pharmaceuticals

Apotex

BE Pharmaceuticals

BluePoint Laboratories

Caplin Steriles

Civica

Fresenius Kabi

Gland Pharma

Hikma

Khandelwal Laboratories

Meitheal

Nivagen Pharmaceuticals

NorthStar Rx

Sandoz

Solco Healthcare

SteriMax

Xiromed

AuroMedics Pharma

Par Pharmaceutical

Piramal Critical Care

Somerset Therapeutics

West-ward Pharmaceutical

Zydus Pharmaceuticals

Hengrui Pharmaceuticals

Jiabo Pharmaceutical

Easton Biopharmaceuticals

Segments

Market Ecosystem

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce glycopyrrolate injection products

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish and enforce quality standards

End users / buyers — receive and administer glycopyrrolate injections

Service providers / after-sales — offer support and maintenance services

Data/analytics providers — provide insights on market trends and product usage

Recent Industry Insights

Analyst Overview

Table of Contents